InvestLog
PTCT PTC Therapeutics, Inc. logo

PTCT PTC Therapeutics, Inc.

Healthcare
$68.81-1.40%ClosedMarket Cap: $5.71B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

4

Dispositions

18

Buy/Sell Ratio

0.22

Net Shares

-61,559

Shares Acquired

18,305

Shares Disposed

79,864

Total Bought ($)

$0.00

Total Sold ($)

$15.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19Boulding Mark Elliottofficer: EXEC. VP AND CLOSell2,356$72.08105,668
Tue May 19Boulding Mark Elliottofficer: EXEC. VP AND CLOSell456$72.67105,212
Tue May 19Boulding Mark Elliottofficer: EXEC. VP AND CLOSell2,812$25.69108,024
Fri May 15Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell7,221$73.08398,670
Fri May 15Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell2,572$72.46393,998
Fri May 15Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell2,100$73.08396,570
Fri May 15Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell679$73.06405,891
Fri May 15Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell12,500$0.00406,570
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell1,900$79.31105,212
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell840$78.23107,112
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell600$79.28105,212
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell200$78.00105,812
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell2,740$46.54107,952
Tue May 12Boulding Mark Elliottofficer: EXEC. VP AND CLOSell800$46.54106,012
Thu Apr 23Klein Matthew B.director, officer: CHIEF EXECUTIVE OFFICERSell2,850$70.91394,070